Pfizer Inc.
PFE
$22.28
-$0.26-1.15%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/30/2025 | 12/31/2024 | 09/29/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 623.66% | -90.82% | 10,790.24% | -98.68% | 192.46% |
| Total Depreciation and Amortization | -9.73% | 2.35% | 1.16% | -0.29% | 3.96% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -120.48% | 523.61% | -2,592.86% | 96.67% | 72.06% |
| Change in Net Operating Assets | -165.58% | 232.88% | 124.87% | -5.97% | -139.48% |
| Cash from Operations | -65.26% | 0.10% | 476.98% | -263.39% | -79.20% |
| Capital Expenditure | 38.50% | -40.86% | -2.20% | 9.52% | 32.57% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 643.63% | 49.79% | -126.85% | 114.98% | -92.72% |
| Cash from Investing | 301.73% | 21.10% | -144.72% | 165.59% | 115.75% |
| Total Debt Issued | -- | -66.13% | -52.71% | 216.48% | -81.18% |
| Total Debt Repaid | 29.49% | 21.74% | 3.82% | -26.79% | -3,611.65% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -2.39% | 0.00% | 0.00% | -0.34% | -2.46% |
| Other Financing Activities | -2,442.86% | -133.33% | 90.48% | 83.68% | -2,044.44% |
| Cash from Financing | -2.21% | -10.31% | -88.53% | 50.13% | -190.61% |
| Foreign Exchange rate Adjustments | 75.86% | -422.22% | 150.00% | 35.71% | -2,700.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -200.00% | -- | -- |
| Net Change in Cash | 931.11% | -255.17% | -91.55% | 116.05% | -578.41% |